Hiroshi Tanaka

23.6k total citations · 1 hit paper
738 papers, 13.2k citations indexed

About

Hiroshi Tanaka is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroshi Tanaka has authored 738 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Molecular Biology, 120 papers in Oncology and 117 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroshi Tanaka's work include Renal Diseases and Glomerulopathies (77 papers), Systemic Lupus Erythematosus Research (50 papers) and Lung Cancer Treatments and Mutations (42 papers). Hiroshi Tanaka is often cited by papers focused on Renal Diseases and Glomerulopathies (77 papers), Systemic Lupus Erythematosus Research (50 papers) and Lung Cancer Treatments and Mutations (42 papers). Hiroshi Tanaka collaborates with scholars based in Japan, United States and China. Hiroshi Tanaka's co-authors include Kaoru Mogushi, Junta Tanaka, Etsuro Ito, Tadaatsu Imaizumi, Kazushi Tsuruga, Shinobu Waga, Suyu Shu, Hirohisa Yoshizawa, Koji Tsugawa and Hiroshi Kagamu and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Hiroshi Tanaka

703 papers receiving 12.8k citations

Hit Papers

Loss of Keap1 Function Activates Nrf2 and Provides Advant... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
    2008 526 citations Tsutomu Ohta, Kumiko Iijima et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Tanaka Japan 52 4.5k 2.1k 2.0k 1.9k 1.8k 738 13.2k
Atsushi Takahashi Japan 74 4.6k 1.0× 1.4k 0.6× 1.8k 0.9× 2.8k 1.5× 2.0k 1.1× 487 19.5k
Takashi Wada Japan 55 3.2k 0.7× 1.5k 0.7× 2.8k 1.4× 2.0k 1.0× 2.0k 1.1× 454 13.5k
David O. Bates United Kingdom 69 7.4k 1.6× 2.9k 1.4× 1.2k 0.6× 1.9k 1.0× 1.6k 0.9× 317 16.6k
Masayuki Yoshida Japan 48 2.9k 0.6× 1.9k 0.9× 1.8k 0.9× 1.7k 0.9× 1.2k 0.7× 370 9.8k
Linda L. Demer United States 65 5.0k 1.1× 1.7k 0.8× 2.4k 1.2× 3.5k 1.9× 2.4k 1.4× 162 17.5k
Peter Boor Germany 62 5.2k 1.1× 1.2k 0.6× 1.6k 0.8× 1.8k 1.0× 1.9k 1.1× 449 14.7k
Bruce Furie United States 72 5.6k 1.2× 1.3k 0.6× 3.3k 1.6× 1.5k 0.8× 1.9k 1.1× 238 19.1k
Kenneth G. Mann United States 93 5.6k 1.2× 1.7k 0.8× 1.1k 0.5× 2.5k 1.3× 3.3k 1.9× 410 27.4k
Gerhard A. Müller Germany 52 3.5k 0.8× 1.1k 0.5× 1.3k 0.7× 1.3k 0.7× 1.4k 0.8× 302 10.5k
Lily Wu United States 59 5.6k 1.2× 2.2k 1.0× 2.1k 1.0× 1.6k 0.8× 1.3k 0.7× 222 13.0k

Countries citing papers authored by Hiroshi Tanaka

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tanaka more than expected).

Fields of papers citing papers by Hiroshi Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tanaka. The network helps show where Hiroshi Tanaka may publish in the future.

Co-authorship network of co-authors of Hiroshi Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tanaka. A scholar is included among the top collaborators of Hiroshi Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tanaka. Hiroshi Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Daishi, Takuya Fujimaru, Seiji Tanaka, et al.. (2024). Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome. Nephrology Dialysis Transplantation. 40(5). 967–977. 3 indexed citations
2.
Yamada, Tadaaki, Yasuhiro Gotô, Hiroshi Tanaka, et al.. (2023). A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study. European Journal of Cancer. 195. 113373–113373. 8 indexed citations
3.
4.
5.
Aizawa, Tomomi, Shojiro Watanabe, Koji Tsugawa, Kensuke Joh, & Hiroshi Tanaka. (2021). Membranous nephropathy associated with Mycoplasma pneumoniae infection. Pediatrics International. 63(7). 853–855. 1 indexed citations
6.
Yamada, Takaaki, Seiji Hasegawa, Yu Inoue, et al.. (2021). Senescent cell removal via JAG1‐NOTCH1 signalling in the epidermis. Experimental Dermatology. 30(9). 1268–1278. 11 indexed citations
7.
Aizawa, Tomomi, Tadaatsu Imaizumi, Koji Tsugawa, et al.. (2021). Effect of sera from lupus patients on the glomerular endothelial fibrinolysis system. Pediatrics International. 64(1). e15099–e15099. 1 indexed citations
8.
Nakao, Mitsuyoshi, Hiroshi Tanaka, & Tomoaki Koga. (2020). Cellular Senescence Variation by Metabolic and Epigenomic Remodeling. Trends in Cell Biology. 30(12). 919–922. 27 indexed citations
9.
Minami, Keita, et al.. (2020). Robot-Assisted Radical Prostatectomy in a Second Kidney Transplant Recipient. Journal of Endourology Case Reports. 6(4). 540–543. 2 indexed citations
10.
Kikuchi, Atsuo, et al.. (2019). Fatal case of Hajdu–Cheney syndrome with idiopathic pulmonary hemosiderosis. Pediatrics International. 61(2). 190–192. 4 indexed citations
11.
Tanaka, Hiroshi. (2019). High prevalence of underlying orthostatic proteinuria in young Japanese women. Pediatrics International. 61(3). 306–307. 2 indexed citations
12.
Tanaka, Hiroshi, Hitoshi Sase, Toshiyuki Tsukaguchi, et al.. (2018). Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer. Molecular Cancer Therapeutics. 17(12). 2519–2529. 17 indexed citations
13.
Tsugawa, Koji, Tadaatsu Imaizumi, Shojiro Watanabe, et al.. (2016). Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells. Clinical and Experimental Nephrology. 21(4). 573–578. 6 indexed citations
14.
Tanaka, Hiroshi, et al.. (2014). Analysis of the kinetic chain including the stretching of the chest in baseball pitching. 114(51). 13–18. 1 indexed citations
15.
Yae, Toshifumi, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.. (2012). Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nature Communications. 3(1). 883–883. 311 indexed citations
16.
Tanaka, Hiroshi, Miyuki Yoshida, Hiromi Tanimura, et al.. (2011). The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations. Clinical Cancer Research. 17(10). 3272–3281. 79 indexed citations
17.
Ohta, Tsutomu, Kumiko Iijima, Mamiko Miyamoto, et al.. (2008). Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth. Cancer Research. 68(5). 1303–1309. 526 indexed citations breakdown →
18.
Miura, Satoru, Hiroshi Kagamu, Hiroshi Tanaka, Hirohisa Yoshizawa, & Fumitake Gejyo. (2008). Appropriate Timing of CD40 Ligation for RNA‐Pulsed DCs to Induce Antitumor Immunity. Scandinavian Journal of Immunology. 67(4). 385–391. 3 indexed citations
19.
Tanaka, Hiroshi, Toyohiro Saikai, & Shosaku Abe. (2000). OCCUPATIONAL HYPERSENSITIVITY PNEUMONITIS. 48(5). 394–398. 3 indexed citations
20.
Tanaka, Hiroshi & C. T. Liang. (1995). Effect of platelet‐derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats. Journal of Cellular Physiology. 164(2). 367–375. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Takahashi Breakdown of academic impact, for papers by Takashi Wada Breakdown of academic impact, for papers by David O. Bates Breakdown of academic impact, for papers by Masayuki Yoshida Breakdown of academic impact, for papers by Linda L. Demer Breakdown of academic impact, for papers by Peter Boor Breakdown of academic impact, for papers by Bruce Furie Breakdown of academic impact, for papers by Kenneth G. Mann Breakdown of academic impact, for papers by Gerhard A. Müller Breakdown of academic impact, for papers by Lily Wu
Rankless by CCL
2026